日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions

欧洲多家机构关于免疫检查点抑制剂治疗晚期肉瘤的真实世界数据

Kokkali, Stefania; Dolcan, Ana; Boye, Kjetil; Kyriazoglou, Anastasios; Boukovinas, Ioannis; Kalofonou, Foteini; Koumarianou, Anna; Asimakopoulou, Natalia; Vorrias, Eleftherios; Tsapakidis, Konstantinos; Georgaki, Eleni; Boulouta, Anna; Mavroeidis, Leonidas; Harneshaug, Magnus; Theocharis, Stamatios; Jones, Robin L; Digklia, Antonia

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial

一项由药剂师主导的跨专业药物依从性计划提高了口服抗癌疗法的依从性:OpTAT随机对照试验

Bandiera, Carole; Cardoso, Evelina; Locatelli, Isabella; Zaman, Khalil; Diciolla, Antonella; Digklia, Antonia; Stravodimou, Athina; Cristina, Valérie; Aedo-Lopez, Veronica; Dolcan, Ana; Sarivalasis, Apostolos; Bouchaab, Hasna; Pasquier, Jérôme; Dotta-Celio, Jennifer; Peters, Solange; Wagner, Dorothea; Csajka, Chantal; Schneider, Marie Paule

Recurrent benign fibrous histiocytoma of the bone benefits from denosumab followed by malignant transformation: a case report

复发性良性骨纤维组织细胞瘤经地诺单抗治疗后发生恶性转化:病例报告

Laureline, Wetterwald; Patrick, Omoumi; Tu, Nguyen; Stephane, Cherix; Ana, Dolcan; Daniela, Ferraro; Chiara, Saglietti; Igor, Letovanec; Antonia, Digklia

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study

OpTAT 研究中,药代动力学模型支持患者坚持服用 CDK 4/6 抑制剂帕博西尼,并省略剂量管理。

Bandiera, Carole; Locatelli, Isabella; Courlet, Perrine; Cardoso, Evelina; Zaman, Khalil; Stravodimou, Athina; Dolcan, Ana; Sarivalasis, Apostolos; Zurcher, Jean-Philippe; Aedo-Lopez, Veronica; Dotta-Celio, Jennifer; Peters, Solange; Guidi, Monia; Wagner, Anna Dorothea; Csajka, Chantal; Schneider, Marie P

Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma

为接受尤文氏肉瘤治疗的成年患者提供最佳的后续护理

Digklia, Antonia; Dolcan, Ana; Kucharczyk, Monika A; Jones, Robin L; Napolitano, Andrea

Response of Brain and Meningeal Metastases to Trastuzumab-Deruxtecan in a Patient with HER2-Low Breast Cancer: A Case Report

HER2低表达乳腺癌患者脑和脑膜转移对曲妥珠单抗-德鲁替康治疗的反应:病例报告

Wolf, Benita; Dunet, Vincent; Dubruc, Estelle; Dolcan, Ana; Nicod Lalonde, Marie; Schiappacasse, Luis; Zaman, Khalil

Exceptional response to PD-1 inhibition immunotherapy in advanced metastatic osteosarcoma with tumor site infection

晚期转移性骨肉瘤伴肿瘤部位感染对PD-1抑制免疫疗法反应显著

Digklia, Antonia; Boughdad, Sarah; Homicsko, Krisztian; Dromain, Clarisse; Trimech, Mounir; Dolcan, Ana; Peters, Solange; Prior, John; Schaefer, Niklaus; Li, Meng; Bao, Qiyuan; Zhang, Zhusheng; Wang, Beichen; Liu, Zhuochao; Wen, Junxiang; Wan, Rong; Shen, Yuhui; Zhang, Weibin

Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients

病例报告:酪氨酸激酶抑制剂诱发纤维瘤患者淋巴结肿大

Papadopoulos, Sotirios; Koulouris, Pantelis; Royer-Chardon, Claire; Tsoumakidou, Georgia; Dolcan, Ana; Cherix, Stephane; Matter, Maurice; Omoumi, Patrick; Digklia, Antonia

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

优化口服靶向抗癌疗法治疗实体瘤患者的研究:一项随机对照药物依从性计划方案,以及药代动力学和药效学数据的系统收集和建模

Bandiera, Carole; Cardoso, Evelina; Locatelli, Isabella; Digklia, Antonia; Zaman, Khalil; Diciolla, Antonella; Cristina, Valérie; Stravodimou, Athina; Veronica, Aedo Lopez; Dolcan, Ana; Sarivalasis, Apostolos; Liapi, Aikaterini; Bouchaab, Hasna; Orcurto, Angela; Dotta-Celio, Jennifer; Peters, Solange; Decosterd, Laurent; Widmer, Nicolas; Wagner, Dorothea; Csajka, Chantal; Schneider, Marie Paule

So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature

伴有BRCA2突变的所谓子宫颈浆液性癌:病例报告及文献复习

Herrera Gómez, Ruth Gabriela; Hastir, Delfyne; Liapi, Aikaterini; Dolcan, Ana; Herrera, Fernanda G; Mathevet, Patrice; Sarivalasis, Apostolos